Scottish Biotech gets €4M from Horizon 2020 for Off-the-Shelf Cell Therapy
TC Biopharm has just received the largest award of its kind to develop allogeneic gamma-delta T…
August 2, 2017 - 3 minutes
Cell therapy
Keep yourself up to date with the latest cell therapy news, including stem cell therapy, CAR-T cell therapy, and more. This section covers the latest updates on regulations, deals, and technology advancements of cell therapy companies.
Regenerating the Body With Stem Cells – Hype or Hope?
When the Japanese researcher Shinya Yamanaka managed to reprogram adult cells into an embryonic-like state…
July 11, 2017 - 9 minutes
Servier Recruits Viral Vector Expert to Step Up its CAR-T Technology
Transgene will help Servier develop new methods based on viral vectors to improve the precision…
June 29, 2017 - 2 minutes
British Biotech Tops up its Cancer Pipeline with New TCR Therapy
Cell Medica just acquired Catapult Therapy TCR, set up by UK's CGT Catapult, gaining the…
June 21, 2017 - 2 minutes
Swedish Biotech publishes Long-Term Data on a Dendritic Cell Therapy for Cancer
Immunicum has reported new data on long-term follow-up of patients treated with ilixadencel, a unique…
June 20, 2017 - 3 minutes
Seed Funding for a German Cell Therapy to Prevent Transplant Rejection
TolerogenixX has proved that it can get rid of immunosuppressants in organ transplants in Phase…
May 24, 2017 - 2 minutes
Celyad gets FDA Fast Track to Tackle Heart Failure with Cell Therapy
Celyad has received Fast Track Designation from the FDA for C-Cure, a cell therapy aimed…
May 11, 2017 - 1 minute
Taking Cell Therapy one Step Further with this Boost Reagent
Cell therapy is revolutionizing medicine, here’s how the latest technology can help overcome the major…
April 12, 2017 - 4 minutes
“In the Coming Decade, Off-the-Shelf Cell Therapy will Become a Reality”
David Sourdive, co-founder of Cellectis, discusses his pioneering work developing off-the-shelf CAR-T for cancer and…
March 16, 2017 - 4 minutes
New Cardiac Stem Cell Therapy passes Phase I/II Trials
TiGenix announces positive one-year results for its phase I/II trial of donor-derived cardiac stem cell therapy in…
March 13, 2017 - 3 minutes
It’s Not Just Regulations: 9 Other Reasons Advanced Therapies Fail
For advanced therapy medicinal products (ATMPs), the regulatory process is a major challenge to reach…
January 18, 2017 - 7 minutes
New German Immuno-oncology Partnership takes on Solid Tumors
TCR2 Therapeutics is initiating a partnership with academia to boost its TCR technology with the…
January 3, 2017 - 2 minutes
